Adenosine inhibits cholangiocarcinoma via a concurrent activation of AMPK and mTORC1 signaling pathways

18 May 2026
0

Adenosine inhibits cholangiocarcinoma via a concurrent activation of AMPK and mTORC1 signaling pathways

Lertsuwan J, Svasti S, Satayavivad J

Anticancer Res. 2026;46(3):1449-1460.

Tags

Share this

Related Posts

Silencing serine/arginine-rich splicing factor 1 to induce apoptosis and autophagy-dependent cell death in cholangiocarcinoma through the correction of oncogenic splicing errors

Recent Posts